Factor Drug Program

Implementation of Factor Drug Program
Effective January 15, 2008

Blue Cross and Blue Shield of Texas and HMO Blue® Texas are happy to announce that they have entered into a new agreement with Hemophilia Health Services, a division of Accredo Health Group Inc. to provide clotting factor to its hemophilia members. Effective January 15, 2008, Accredo will be the exclusive HMO provider* and the Preferred BlueChoice® PPO/POS provider for all Factor Products. HMO members requiring factor products must be directed to Accredo by their physician effective January 15th. PPO subscribers should be directed to Accredo as the preferred provider effective January 15th, however subscribers can continue to receive factor products from contracted PPO providers based on the terms of their PPO provider agreement.

The list of “Factor Products” is listed below and is also identified in the Home Infusion Therapy Drug Schedule posted on the BCBSTX Provider Web site (the list is subject to change in accordance with the terms of your agreement).

Factor Products:

• J7187
• J7189
• J7190
• J7192
• J7193
• J7194
• J7195
• J7198

* Exception: Factor products may be provided by an HMO member’s treating physician or by other specific providers identified by BCBSTX.

To refer your members to Accredo, please contact Accredo at (800) 800-6606 and ask to speak with a pharmacist.